Perform Another (Advanced) Search

1.  Study Posting (77) Trial #152710, Skin Cancer, New York, NY
...Study Posting (77) Trial #152710, Skin Cancer, New York, NY Trial Information Skin Cancer - Organ Transplant Patients ATTENTION ORGAN TRANSPLANT PATIENTS WHO HAVE ACTINIC KERATOSES AND HAVE HAD BASAL-CELL OR ...
View Page

2.  Study Posting (1819) Trial #88710, Organ Transplant - Pediatric, Cincinnati, OH
...Study Posting (1819) Trial #88710, Organ Transplant - Pediatric, Cincinnati, OH Trial Information A Phase II Study of the Combination of Cyclophosphamide, Prednisone ...
View Page

3.  Study Posting (1819) Trial #88709, Organ Transplant, Cincinnati, OH
...Study Posting (1819) Trial #88709, Organ Transplant, Cincinnati, OH Trial Information A Phase II Study of the Combination of Cyclophosphamide, Prednisone and ...
View Page

4.  Study Posting (4519) Trial #123196, Cytomegalovirus Infections, Valencia, Spain
...Infections, Valencia, Spain Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

5.  Study Posting (4519) Trial #122658, Cytomegalovirus Infections, Madrid, Spain
...Infections, Madrid, Spain Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

6.  Study Posting (4519) Trial #123847, Cytomegalovirus Infections, Guadalajara, Mexico
...Infections, Guadalajara, Mexico Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

7.  Study Posting (4519) Trial #122499, Cytomegalovirus Infections, Berlin, Germany
...Infections, Berlin, Germany Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

8.  Study Posting (4519) Trial #123009, Cytomegalovirus Infections, Paris, France
...Infections, Paris, France Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

9.  Study Posting (4519) Trial #147289, Cytomegalovirus Infections, Westmead, Australia
...Infections, Westmead, Australia Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

10.  Study Posting (4519) Trial #122269, Cytomegalovirus Infections, Parkville, Australia
...Infections, Parkville, Australia Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

11.  Study Posting (4519) Trial #147706, Cytomegalovirus Infections, Pittsburgh, PA
...Infections, Pittsburgh, PA Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

12.  Study Posting (4519) Trial #147681, Cytomegalovirus Infections, Cincinnati, OH
...Infections, Cincinnati, OH Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

13.  Study Posting (4519) Trial #123705, Cytomegalovirus Infections, Indianapolis , IN
...Infections, Indianapolis , IN Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

14.  Study Posting (4519) Trial #123428, Cytomegalovirus Infections, Mexico City, Mexico
...Mexico City, Mexico Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

15.  Study Posting (4519) Trial #123501, Cytomegalovirus Infections, Winnipeg, MB, Canada
...Winnipeg, MB, Canada Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

16.  Study Posting (4519) Trial #122365, Cytomegalovirus Infections, Edmonton, AB, Canada
...Edmonton, AB, Canada Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

17.  Study Posting (4519) Trial #124117, Cytomegalovirus Infections, New York, NY
...New York, NY Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

18.  Study Posting (4519) Trial #125842, Cytomegalovirus Infections, St Louis, MO
...St Louis, MO Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

19.  Study Posting (4519) Trial #124710, Cytomegalovirus Infections, Ann Arbor, MI
...Ann Arbor, MI Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page

20.  Study Posting (4519) Trial #123967, Cytomegalovirus Infections, Los Angeles, CA
...Los Angeles, CA Trial Information A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients Status: Completed Protocol Number: WV16726 Sponsor: Hoffmann-La Roche Company Division: Pharmaceutical Official Scientific ...
View Page